Date: November 18, 2019
The U.S. Trade and Development Agency welcomes businesses to meet with high-level officials from China’s National Medical Products Administration (NMPA) during a one-day workshop and industry reception in Washington, DC. USTDA is sponsoring NMPA’s visit to the United States so that U.S. firms can showcase their technologies and capabilities, as well as discuss opportunities for partnership and collaboration. During this visit, NMPA officials will also receive training on U.S. policies and procedures related to the review and approval of medical devices, with a focus on post-market.
China is making changes to its healthcare sector and regulatory processes. In 2018, NMPA replaced the China Food and Drug Administration as the government agency responsible for regulating drugs and medical devices. NMPA drafts laws and regulations for drugs, medical devices and cosmetics, as well as establishes medical device standards and classification systems. Amended China Medical Device regulations allow for acceptance of self-test reports for some Class II and III medical devices (the most complex medical devices) and increased recognition of clinical trial data obtained from countries outside of China. The market for medical devices in China has grown substantially over the last decade and presents significant opportunities for U.S. industry.
The Webster Group is organizing the Workshop on behalf of USTDA. For more information about how to participate, please contact email@example.com.